Directory of funded grants

Filter by

725 results found

Myelin loss and cognitive impairment following SARS-CoV-2 infection 

  • Area of research

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Competition

    Alzheimer’s Association International Grant Program

  • Province

    Ontario

  • Start Date

    2025

  • Total Grant Amount

    $159,997

  • Health Canada Contribution

    $63,635

Project Overview

Does SARS-CoV-2 infection increase cognitive decline via myelin loss in older individuals? Background: One in 4 persons infected with SARS-CoV-2 (the COVID-19 virus) shows cognitive decline. This decline could be related to white matter damage. The white matter is made of axons connecting neurons with each other. The integrity of…

CODEX Trial

  • Grant Type

    Capacity building grants

  • Area of research

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Competition

    Alzheimer’s Association International Grant Program

  • Province

    Ontario

  • Start Date

    2024

  • Total Grant Amount

    $200,000

  • Health Canada Contribution

    $90,910

Project Overview

Each year, over 312 million patients undergo surgery. Anesthesia is a drug-induced reversible, comatose state that facilitates surgery. It is widely assumed cognition returns to baseline afterwards. Surgery and anesthesia induce stress responses in the body, potentially damaging brain cells. Many patients develop postoperative neurocognitive disorders (PND), including delirium (fluctuating…

The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): Building a Research, Practice and Policy Foundation

  • Area of research

    Mental Health

  • Competition

    2024 CCS Breakthrough Team Grants - Transforming the future of metastatic cancer

  • Province

    Alberta

  • Start Date

    2025

  • Total Grant Amount

    $5,478,935

  • Health Canada Contribution

    $413,500

Project Overview

A new national initiative funded by the Canadian Cancer Society, the Canadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT), is bringing together researchers, clinicians, policymakers, and people living with advanced cancer to explore the potential of psychedelic-assisted therapy as a transformative approach to cancer care. People with advanced cancer often experience…

Transforming Palliative Care for People Living with Advanced Cancer: Developing a National Research Platform

  • Area of research

    Mental Health

  • Competition

    2024 CCS Breakthrough Team Grants - Transforming the future of metastatic cancer

  • Province

    Ontario

  • Start Date

    2025

  • Total Grant Amount

    $5,899,008

  • Health Canada Contribution

    $562,122

Project Overview

Palliative care (PC) is an area of medicine that focuses on symptom control and quality of life of patients with life-limiting illnesses and their families. PC can be provided at any point in the cancer experience, even alongside cancer treatments. PC can improve symptoms and quality of life, but the…

Novel Repetitive Transcranial Magnetic Stimulation Paradigm to Reduce Cortical Hyperexcitability in Patients with ALS

  • Area of research

    Neurodegeneration

  • Disease Area

    ALS

  • Competition

    ALS Canada - Brain Canada Discovery Grants

  • Province

    Ontario

  • Start Date

    2025

  • Total Grant Amount

    $125,000

  • Health Canada Contribution

    $62,500

Project Overview

ALS is a devastating neurological disease characterized by the progressive degeneration of motor neurons leading to paralysis and death. Although the exact cause of ALS remains unknown in the majority of patients, abnormalities in the motor cortex of the brain can be detected early in the disease and may be…